2011 Portfolio News
News from the portfolios of HBM BioVentures and HBM BioCapital
Delenex extends its A round to CHF 30.2 million (167 KB)3.5.2011
- Nabriva reports positive results from phase II trial of Pleuromutilin antibiotic BC-3781 in ABSSSI (43 KB)
18.4.2011
- Anthera Pharmaceuticals successfully completes Interim Biomarker analysis of VISTA-16 study and third review of Varespladib Methyl (14 KB)
18.4.2011
- Mpex Pharmaceuticals, Inc. to be acquired by Axcan (36 KB)
14.4.2011
- Pacira Pharmaceuticals, Inc. announces pricing of its Initial Public Offering (53 KB)
3.2.2011
- HBM BioVentures: Successful sale of indirect holing in China Health System generates cash inflow of approximately USD 17 million (41 KB)
1.4.2011
- PTC Therapeutics appoints Robert Spiegel, M.D. as Chief Medical Officer (8 KB)
30.3.2011
- Valeant Pharmaceuticals to acquire PharmaSwis S.A. (42 KB)
1.2.2011
- Successful sale of HBM portfolio company PharmaSwiss to Valeant (37 KB)
1.2.2011
- HBM BioVentures realises a profit of EUR 41.9 million through the sale of PharmaSwiss to Valeant (44 KB)
1.2.2011
- MiCardia Corp.: Optimizing mitral valve repair (389 KB)
31.1.2011
News
M&A Report
Links
Subscribe To Our Newsletter
Search
© HBM Partners AG 18.05.2012